milrinone has been researched along with Bone Loss, Osteoclastic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cardiotonic agent amrinone inhibits bone resorption in vitro." | 1.27 | Cardiotonic agent milrinone stimulates resorption in rodent bone organ culture. ( Krieger, NS; Stappenbeck, TS; Stern, PH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, K | 1 |
| Waki, Y | 1 |
| Horita, T | 1 |
| Kasugai, S | 1 |
| Ohya, K | 1 |
| Krieger, NS | 1 |
| Stappenbeck, TS | 1 |
| Stern, PH | 1 |
2 other studies available for milrinone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imi | 1997 |
Cardiotonic agent milrinone stimulates resorption in rodent bone organ culture.
Topics: Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcium; Cardiotonic Agents; Cyclic AMP; | 1987 |